These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16721003)

  • 1. MIA syndrome in peritoneal dialysis: prevention and treatment.
    Shahab I; Nolph KD
    Contrib Nephrol; 2006; 150():135-143. PubMed ID: 16721003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of conventional versus biocompatible peritoneal dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients.
    Stankovic-Popovic V; Nesic V; Popovic D; Maksic D; Colic M; Vasilijic S; Vucinic Z; Milicic B; Radjen S; Dimkovic N
    Clin Nephrol; 2011 Oct; 76(4):314-22. PubMed ID: 21955867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.
    Tonbul HZ; Demir M; Altintepe L; Güney I; Yeter E; Türk S; Yeksan M; Yildiz A
    Ren Fail; 2006; 28(4):287-94. PubMed ID: 16771243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.
    Koo HM; Do HM; Kim EJ; Lee MJ; Shin DH; Kim SJ; Oh HJ; Yoo DE; Kim JK; Park JT; Han SH; Kang SW; Choi KH; Yoo TH
    Atherosclerosis; 2011 Dec; 219(2):925-30. PubMed ID: 22015178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between self-management ability and malnutrition-inflammation-atherosclerosis syndrome in peritoneal dialysis patients: a cross-sectional study.
    Huang Z; Fang J; Song A; Tong Y; Deng H; Wei S; Ji O; Hu C; Li P; Zhang C; Liu Y
    BMC Nephrol; 2021 Jan; 22(1):13. PubMed ID: 33413177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum thymosin β4 with malnutrition-inflammation-atherosclerosis syndrome in peritoneal dialysis patients: a cross-sectional study.
    Tian J; Zhang R; Zhu N; Gu L; Guo Y; Yuan W
    Ren Fail; 2023 Dec; 45(1):2202761. PubMed ID: 37133832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowel bacterial overgrowth as another cause of malnutrition, inflammation, and atherosclerosis syndrome in peritoneal dialysis patients.
    Aguilera A; Gonzalez-Espinoza L; Codoceo R; Jara Mdel C; Pavone M; Bajo MA; Del Peso G; Celadilla O; Martínez MV; López-Cabrera M; Selgas R
    Adv Perit Dial; 2010; 26():130-6. PubMed ID: 21348395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of malnutrition in peritoneal dialysis patients].
    Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B; Levaltier B; Ryckelynck JP
    Nephrologie; 2003; 24(7):387-9. PubMed ID: 14650752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular water expansion: part of the malnutrition-inflammation-atherosclerosis syndrome?
    Woodrow G
    Perit Dial Int; 2006; 26(5):566-70. PubMed ID: 16973511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of MIA syndrome in peritoneal dialysis patients].
    Tasić D
    Med Pregl; 2007; 60 Suppl 2():170-2. PubMed ID: 18928187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients.
    Ho LC; Wang HH; Chiang CK; Hung KY; Wu KD
    Blood Purif; 2010; 30(1):16-24. PubMed ID: 20588008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients].
    de Mutsert R; Krediet RT
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2023-7. PubMed ID: 17058458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malnutrition, inflammation, atherosclerosis in hemodialysis patients.
    Jeznach-Steinhagen A; Słotwiński R; Szczygieł B
    Rocz Panstw Zakl Hig; 2007; 58(1):83-8. PubMed ID: 17711095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD membrane: biological responses to different PD fluids.
    Jörres A; Witowski J
    Contrib Nephrol; 2006; 150():48-53. PubMed ID: 16720991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis and inflammation.
    Velloso MS; Otoni A; de Paula Sabino A; de Castro WV; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2014 Mar; 430():109-14. PubMed ID: 24333488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammation in peritoneal dialysis].
    Ryckelynck JP; Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B
    Nephrologie; 2003; 24(7):367-70. PubMed ID: 14650748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From MIA to FIFA: The vicious matrix of frailty, inflammation, fluid overload and atherosclerosis in peritoneal dialysis.
    Chan GC; Fung WW; Szeto CC; Ng JK
    Nephrology (Carlton); 2023 Apr; 28(4):215-226. PubMed ID: 36807408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malnutrition, inflammation, atherosclerosis syndrome in diabetes mellitus peritoneal dialysis patients--report of 16 cases].
    Chen MH; Wang T
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1823-4. PubMed ID: 15631782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.